IMAX Corporation:企業のM&A・事業提携・投資動向

◆英語タイトル:IMAX Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C2286
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:67
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:技術・通信
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

IMAX Corporation – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s IMAX Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by IMAX Corporation since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes IMAX Corporation’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by IMAX Corporation. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on IMAX Corporation’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by IMAX Corporation and its subsidiaries since 2007.
- Information about key financial and legal advisors for IMAX Corporation’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about IMAX Corporation’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
CORPORATE VENTURING 8
Corporate Venturing – Overview 8
Corporate Venturing – Deal reports 9
PARTNERSHIP 15
Partnership – Overview 15
Partnership – Deal reports 16
CAPITAL RAISING 47
Capital Raising – Deal reports 47
DIVESTMENTS 53
Divestments – Overview 53
Divestments – Deal reports 54
APPENDIX 57
Contact Us 57
About MarketLine Financial Deals Database 57
Deal Definition and Methodology 59
About MarketLine 66

List of Tables
Table 1: IMAX Corporation corporate venturing volume and value trend (2014-YTD2018)
Table 2: IMAX Corporation corporate venturing by geography (2014-YTD2018)
Table 3: IMAX Corporation partnership volume and value trend (2014-YTD2018)
Table 4: IMAX Corporation partnership trend by key deal type (2014-YTD2018)
Table 5: IMAX Corporation divestments volume and value trend (2014-YTD2018)
Table 6: IMAX Corporation divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: IMAX Corporation corporate venturing volume and value trend (2014-YTD2018)
Figure 2: IMAX Corporation corporate venturing by geography (2014-YTD2018)
Figure 3: IMAX Corporation partnership volume and value trend (2014-YTD2018)
Figure 4: IMAX Corporation partnership trend by key deal type (2014-YTD2018)
Figure 5: IMAX Corporation divestments volume and value trend (2014-YTD2018)
Figure 6: IMAX Corporation divestments by geography (2014-YTD2018)

★海外企業調査レポート[IMAX Corporation:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PYCTX Ltd (PYC):企業の財務・戦略的SWOT分析
    Summary PYCTX Ltd (PYCTX), formerly Phylogica Ltd is a biotechnology company that develops intracellular biological therapeutics. The company utilizes proprietary phylomer peptide libraries and screening methodologies to identify unique peptide drug candidates. Its products include libraries and pep …
  • Saft Groupe SA:企業の戦略的SWOT分析
    Saft Groupe SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • ImpediMed Ltd (IPD):企業の財務・戦略的SWOT分析
    ImpediMed Ltd (IPD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • The Second Cup Ltd.
    The Second Cup Ltd. - Strategy, SWOT and Corporate Finance Report Summary The Second Cup Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Mission Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Mission Therapeutics Ltd (Mission) is a provider of deubiquitylating enzyme drug discovery and development programs. The company develops USP30, USP10 and UHCL1 for patients with mitochondria diseases, neurodegeneration, inflammation and others. the company uses its proprietaryDUB platform t …
  • British Polythene Industries Plc:企業の戦略・SWOT・財務分析
    British Polythene Industries Plc - Strategy, SWOT and Corporate Finance Report Summary British Polythene Industries Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Insurance Corporation of Barbados Limited:企業の戦略・SWOT・財務情報
    Insurance Corporation of Barbados Limited - Strategy, SWOT and Corporate Finance Report Summary Insurance Corporation of Barbados Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Doosan Fuel Cell America Inc:電力:M&Aディール及び事業提携情報
    Summary Doosan Fuel Cell America Inc (Doosan Fuel Cell), formerly Quantum Leap Technology Inc, a subsidiary of Doosan Corp, is a energy solution provider that manufactures and markets clean energy solutions. The company provides installation, remote monitoring and control, equipment service, financi …
  • First Majestic Silver Corp:企業の戦略・SWOT・財務情報
    First Majestic Silver Corp - Strategy, SWOT and Corporate Finance Report Summary First Majestic Silver Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Veritas Genetics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Veritas Genetics Inc (Veritas Genetics) is a genome sequencing company that offers genomics testing and sequencing products and services. The company delivers actionable genetic insights to individuals and their doctors based on their DNA to manage their disease risk and plan their family he …
  • Cementir Holding SpA:企業の戦略・SWOT・財務情報
    Cementir Holding SpA - Strategy, SWOT and Corporate Finance Report Summary Cementir Holding SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Serco Group plc:企業の戦略・SWOT・財務情報
    Serco Group plc - Strategy, SWOT and Corporate Finance Report Summary Serco Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Allied Irish Banks, Plc:戦略・SWOT・企業財務分析
    Allied Irish Banks, Plc - Strategy, SWOT and Corporate Finance Report Summary Allied Irish Banks, Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • J. Front Retailing Co Ltd:企業の戦略・SWOT・財務分析
    J. Front Retailing Co Ltd - Strategy, SWOT and Corporate Finance Report Summary J. Front Retailing Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Tessa Therapeutics Pte Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Tessa Therapeutics Pte Ltd (Tessa Therapeutics) is a clinical-stage biotechnology company that discovers, develops, and commercializes cancer immunotherapies that redirect the body’s powerful anti-viral immune response and identify and exterminate cancer cells. The company provides products …
  • Vietnam Electricity:企業の戦略的SWOT分析
    Vietnam Electricity - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Odfjell SE (ODF):石油・ガス:M&Aディール及び事業提携情報
    Summary Odfjell SE (Odfjell) is a shipping company that provides transportation and carrier services for various minerals and oils. The company transports organic and inorganic chemicals, petroleum products, lubricating oils, edible oils, acids, animal fats and portable alcohols. Odfjell owns and op …
  • Qatar Islamic Bank
    Qatar Islamic Bank - Strategy, SWOT and Corporate Finance Report Summary Qatar Islamic Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Kresta Holdings Limited (KRS):企業の財務・戦略的SWOT分析
    Kresta Holdings Limited (KRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • ProQR Therapeutics NV (PRQR):企業の財務・戦略的SWOT分析
    Summary ProQR Therapeutics NV (ProQR) is a clinical-stage biotech company that discovers and develops drugs for the treatment of genetic disorders. The company’s lead product candidate includes QR-010, a RNA-based oligonucleotide used for the treatment of cystic fibrosis; QR-110, an oligonucleotide …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆